Evidence map›Paper›PMID 40388903›Full record

ArticleACS synthetic biology2025

PERRC: Protease Engineering with Reactant Residence Time Control.

Sage Nelson, Jokent Gaza, Seyednima Ajayebi, Ronald Masse, Raymond Pho, Cianna Scutero, Samantha Martinusen, Lawton Long, Amor Menezes, Alberto Perez and 1 more

Abstract read
In one paragraph

Article in ACS synthetic biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sage NelsonDepartment of Chemical Engineering, University of Florida, Gainesville 32611, United States.ORCID 0000-0002-6397-6102
Jokent GazaDepartment of Chemistry, University of Florida, Gainesville 32611, United States.ORCID 0000-0002-7836-4539
Seyednima AjayebiDepartment of Chemical Engineering, University of Florida, Gainesville 32611, United States.
Ronald MasseGenetics Institute, University of Florida, Gainesville 32611, United States.ORCID 0000-0001-9478-8748
Raymond PhoDepartment of Chemical Engineering, University of Florida, Gainesville 32611, United States.
Cianna ScuteroDepartment of Chemical Engineering, University of Florida, Gainesville 32611, United States.
Samantha MartinusenDepartment of Chemical Engineering, University of Florida, Gainesville 32611, United States.
Lawton LongDepartment of Chemical Engineering, University of Florida, Gainesville 32611, United States.
Amor MenezesGenetics Institute, University of Florida, Gainesville 32611, United States.ORCID 0000-0003-3923-5766
Alberto PerezDepartment of Chemistry, University of Florida, Gainesville 32611, United States.
Carl DenardDepartment of Chemical Engineering, University of Florida, Gainesville 32611, United States.ORCID 0000-0002-2804-9426

Funding

Reprogramming proteases: tackling human diseases with next-generation modulatorsR35GM146821 · NIGMS · UNIVERSITY OF FLORIDA · PI Carl Denard · 2022 to 2026
$1.6M
NIGMS NIH HHS R35 GM146821
6 · The paper itself

Abstract

Proteases with engineered specificity hold great potential for targeted therapeutics, protein circuit construction, and biotechnology applications. However, many proteases exhibit broad substrate specificity, limiting their use in such applications. Engineering protease specificity remains challenging because evolving a protease to recognize a new substrate, without counterselecting against its native substrate, often results in high residual activity on the original substrate. To address this, we developed Protease Engineering with Reactant Residence Time Control (PERRC), a platform that exploits the correlation between endoplasmic reticulum (ER) retention sequence strength and ER residence time. PERRC allows precise control over the stringency of protease evolution by adjusting counterselection to selection substrate ratios. Using PERRC, we evolved an orthogonal tobacco etch virus protease variant, TEVESNp, that selectively cleaves a substrate (ENLYFES) that differs by only one amino acid from its parent sequence (ENLYFQS). TEVESNp exhibits a remarkable 65-fold preference for the evolved substrate, marking the first example of an engineered orthogonal protease driven by such a slight difference in substrate recognition. Furthermore, TEVESNp functions as a competent protease for constructing orthogonal protein circuits in bacteria, and molecular dynamics simulations analysis reveals subtle yet functionally significant active site rearrangements. PERRC is a modular dual-substrate display system that facilitates precise engineering of protease specificity.

Indexed as

EndopeptidasesProtein EngineeringEndoplasmic ReticulumEscherichia coliMolecular Dynamics SimulationPotyvirusSubstrate SpecificityEndopeptidasesTEV proteasehigh-throughput screeningprotease engineeringsynthetic biologytobacco etch virus (TEV) proteaseyeast surface display

Identifiers

PMID40388903
PMCPMC12301959

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.